{"id":72720,"date":"2025-08-16T12:46:09","date_gmt":"2025-08-16T12:46:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/72720\/"},"modified":"2025-08-16T12:46:09","modified_gmt":"2025-08-16T12:46:09","slug":"these-asx-200-shares-could-rise-30-to-50","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/72720\/","title":{"rendered":"These ASX 200 shares could rise 30% to 50%+"},"content":{"rendered":"

\"Overjoyed<\/p>\n

Image source: Getty Images<\/p>\n

Are you on the hunt for some big returns to take your portfolio to the next level? If you are, then read on!<\/p>\n

That’s because the ASX 200 shares listed below have been named as buys and tipped to rise strongly from where they currently trade.<\/p>\n

Here’s what brokers are saying about them:<\/p>\n

Clarity Pharmaceuticals Ltd (ASX: CU6<\/a>) <\/p>\n

The team at Bell Potter thinks that Clarity Pharmaceuticals could be an ASX 200 share to buy for big returns.<\/p>\n

It is a pharmaceuticals company focused on the development of targeted copper theranostics (TCT) for the imaging and treatment of select cancers.<\/p>\n

Bell Potter was pleased with the company’s recent capital raising and believes it is now fully funded for its full clinical program. As a result, the broker put a speculative buy rating and $5.70 price target on the ASX 200 share. This suggests that upside of 55% is possible between now and this time next year (with potentially even more). It explains:<\/p>\n

CU6 is now funded to complete the full clinical program in prostate cancer including both imaging trials and a future approval study for its therapeutic ( 67Cu SAR bis PSMA). The certainty of the funding decreases the overall risk profile of the group in addition to providing a stronger position from which to negotiate future terms of a distribution deal in the US. Valuation raised to $5.70. On an un-risked basis (reducing clinical trial risk to nil for mCRPC only), the valuation increases to ~$13 representing a market cap of A$4.8bn (US$3.1bn) which is not unreasonable compared to prior transactions in the sector.<\/p>\n

Treasury Wine Estates Ltd (ASX: TWE<\/a>) <\/p>\n

The team at Morgans thinks that this wine giant’s shares are being seriously undervalued by the market.<\/p>\n

In response to its full year results release last week, the broker retained its buy rating with a $10.10 price target. This implies potential upside of approximately 30% for investors over the next 12 months. It said:<\/p>\n

TWE’s FY25 result was in line with guidance, reporting a credible 17% growth in EBITS during a period of macro-economic and category headwinds. TWE is targeting further EBITS growth in FY26, led by Penfolds. We have made modest changes to our forecasts reflecting the disruption associated with a change of distributor in California. While lacking near term share price catalysts given industry and macro headwinds and a CEO transition, trading on an FY26F PE of only 12.7x, we maintain a BUY rating. A$200m share buyback should provide some degree of share price support.<\/p>\n","protected":false},"excerpt":{"rendered":"Image source: Getty Images Are you on the hunt for some big returns to take your portfolio to…\n","protected":false},"author":2,"featured_media":72721,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[64,63,99,8428,7037,7038,7039,7040,56770,56771],"class_list":["post-72720","post","type-post","status-publish","format-standard","has-post-thumbnail","category-business","tag-au","tag-australia","tag-business","tag-category-brokers","tag-partner-feeds-msn-9","tag-partner-feeds-newstex","tag-partner-feeds-sharesight","tag-partner-feeds-webull","tag-tickers_global-asx-cu6","tag-tickers_global-asx-twe"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/72720","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=72720"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/72720\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/72721"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=72720"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=72720"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=72720"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}